The drug maker expects sales from the Pfizer alliance to contribute some 25% to its total sales in four years.

Dan Vasella, the chief executive of Swiss firm Novartis, which has been struggling for the last five years to secure the patent rights in India on Glivec, its therapy for a rare form of blood cancer called chronic myeloid leukemia, has spoken again on the alleged gaps in the Indian patent system.

Model N, a revenue management solutions provider for pharmaceutical, medical devices and biotech companies, on Wednesday said it would invest $8 million in its India operations by financial year 2010-2011.

Denmark-based world leader in diabetes care Novo Nordisk can look at making India the hub for manufacturing insulin for the sub-continent. The company today inaugurated a dedicated facility with a capacity of 26 million vials per annum in partnership with Ahmedabad based Torrent Pharmaceuticals Ltd. Torrent has been manufacturing insulin for Novo Nordisk since the early nineties.